查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
采血市场增长、趋势、COVID-19 的影响和预测 (2023-2028)
市场调查报告书
商品编码
1190108

采血市场增长、趋势、COVID-19 的影响和预测 (2023-2028)

Blood Collection Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，采血市场预计将以 6.2% 的复合年增长率增长。

预计 COVID-19 在世界范围内的爆发将对市场产生积极影响，因为血液检测涉及检测不同的血液样本，以帮助诊断 COVID-19 等传染病。预计。 测试仍然是控制 COVID-19 流行病的重要步骤。 随着全球 COVID-19 病例数量的增加，世界各国政府正在探索允许私人实验室加强血液检测的可能性。 此外，病毒爆发已经耗尽了血液储备。 许多因 COVID-19 而住院的免疫功能低下者需要输血或血浆。 此外，许多政府正在采取措施帮助增加献血量。 例如，2020 年 6 月，印度马哈拉施特拉邦政府通过社交媒体举措增加了献血量。 这是为应对该地区血液短缺问题而采取的措施。 此类项目在大流行期间对许多地区的全球采血市场的增长产生了积极影响。

推动市场增长的具体因素包括对慢性病早期诊断的需求增加、外伤和事故发生率增加以及全球外科手术数量激增。

此外，由于血液病、肾脏病、代谢病、神经病等各种疾病患者的增多，采血需求也很大。 英国血栓形成、淋巴瘤、骨髓瘤和骨髓增生异常综合征 (MDS) 等癌症会影响骨髓、血细胞、淋巴结和淋巴系统的其他部分。 已经证实单采血液分离技术用于减少白细胞计数，直到它们可以用其他药物控制。 根据英国贫血和淋巴瘤协会 (LLS) 2021 年情况说明书，美国大约每 3 分钟就有 1 人被诊断出患有血癌。 此外，同样的数据表明，2021 年美国将有 186,400 人被诊断患有英国贫血/淋巴瘤。 此外，美国有 825,651 人患有淋巴瘤，152,671 人患有霍奇金淋巴瘤，672,980 人患有非霍奇金淋巴瘤。

此外，事故数量的增加也在推动市场的增长。 根据世界卫生组织 (WHO) 的数据，到 2020 年，道路交通事故每年将导致 135 万人死亡，20-5000 万人将遭受非致命伤害。 事故的增加推动了对血液製品的需求，推动了市场的增长。

在预测期内，患有这些疾病和病症的患者数量稳步增加以及事故数量增加可能会提振血液采样市场。 然而，血液污染、其他并发症和采血过程中的伤害是研究市场的主要限制因素。

主要市场趋势

针头和注射器有望占据重要的市场份额

要快速检测 COVID-19 病例，就需要广泛使用诊断方法来遏制病毒的快速传播。 决定了公共卫生紧急情况，授权紧急使用体外诊断 (IVD) 来诊断 COVID-19，并最终在世界范围内推动血液检测。稻田。 因此，预计针头和注射器部分在预测期内将呈现健康增长。 使用皮下注射针头和注射器是最常用的采血方法。 因此，采血针头和注射器因其在世界范围内的广泛使用而有望主导市场。

除了大流行之外，许多其他传染病也在流行，增加了对诊断性血液样本采集的需求，进而推动了对采血针头和注射器的需求。 例如，题为“The Order of Draw during Blood Collection”的研究题为“The Order of Draw during Blood Collection”。 A Systematic Literature Review”（发表于 MDPI Journal，2021 年 2 月）将带有针头的注射器列为常见的开放式采血系统。 注射器是抽血师采血工具包的重要组成部分。 因此，在预测期内，前部采血对注射器和针头的需求推动了该部门的增长。

此外，医疗器械领域的各种进步也在推动市场增长。 例如，根据 2020 年 9 月在 Hindwi Journal 上发表的题为“Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles”的研究，现在在多种情况下使用硅化针头来最大限度地减少创伤，并使用短斜角来最大限度地减少风险静脉交叉穿孔。 在从静脉中取出侵入性装置后的几秒钟内会发生大量伤害，因此大多数市售针头可在穿刺部位提供即时保护。 因此，该行业有望在预测期内保持其在全球市场的主导地位。

北美主导市场，预计在预测期内也会如此

由于对采血用品的需求不断增加，北美的份额最大。 交通事故的增加和慢性病患病率的上升是推动所研究市场增长的主要因素。 COVID-19 对美国的影响最大，预计在预测期内市场将强劲增长。

根据美国红十字会对 2021 年的最新估计，美国每天需要大约 36,000 个单位的红细胞，每年大约需要输注 2100 万份血液成分。 此外，根据 Globocan 2020 报告，加拿大到 2020 年将有 8,506 例非霍奇金淋巴瘤病例和 313 例死亡病例。 预计非霍奇金淋巴瘤病例数量的增加将提振血液采集市场的需求。

然而，国内主要市场参与者赢得的各种策略预示着市场的增长。 例如，2021 年 12 月，获得美国病理学家协会认可并被公认为诊断测试服务领导者的 Ethos Laboratories 将推出 Tru-Immune，这是一种用于 COVID-19 中和抗体测试的指尖自采试剂盒。

此外，在 2021 年 12 月，我们收购了一家简单的采血设备製造商 Tasso。 在 2020 年年中筹集 1700 万美元启动运营后，该公司又筹集了 1 亿美元用于扩大先进家用采血设备的生产和商业部署。 越来越多的慢性病和与生活方式有关的疾病需要采血进行诊断，从而促进了该地区的市场增长。

竞争格局

采血市场竞争激烈，由几家大型企业组成。 Becton、Dickinson and Company、Cardinal Health、F.L. Medical SRL、Greiner Bio-One International GmbH、Haemonetics Corporation、Henry Schein Inc、McKesson Corporation、Medline Industries Inc、PreQ Systems 和 Qiagen 等公司占据了很大的市场份额。 .

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 对慢性病早期诊断的需求不断增长
    • 受伤和事故发生率增加
    • 全球外科手术数量增加
  • 市场製约因素
    • 血液污染和其他并发症
    • 采血过程中受伤
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（市场规模/货币基础）

  • 按产品分类
    • 针头，注射器
    • 试管（血浆分离管、血清分离管等）
    • 柳叶刀
    • 血袋
    • 其他产品
  • 通过申请
    • 诊断
    • 治疗
  • 最终用户
    • 医院和诊断中心
    • 血库
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Becton, Dickinson and Company
    • Cardinal Health
    • Terumo Corporation
    • FRESENIUS KABI
    • Haemonetics Corporation
    • Henry Schein Inc.
    • McKesson Corporation
    • Medline Industries Inc.
    • PreQ Systems
    • Qiagen
    • Grifols
    • Smiths Medical
    • Quest Diagnostics
    • Nipro Medical Corporation

第7章 市场机会今后动向

简介目录
Product Code: 66769

The Blood Collection Market is expected to grow at a CAGR of 6.2% during the forecast period, 2022-2027.

The outbreak of COVID-19 worldwide is expected to positively impact the market because blood testing involves the testing of various blood samples, which helps diagnose infectious diseases such as COVID-19. Testing remains a crucial step in controlling the COVID-19 pandemic. As the number of COVID-19 cases is increasing worldwide, governments across the globe are exploring the possibilities of allowing private laboratories to ramp up blood testing. Moreover, the blood reserves have been depleting due to the virus outbreak. Many individuals with weak immune systems who have been infected by COVID-19 and are hospitalized need a blood/plasma transfusion. Many governments are also taking initiatives to help increase blood donation. For instance, in June 2020, the Maharashtra state government in India used social media initiatives to increase the number of blood donations. The move was taken following the shortage of blood in the region. Such programs have positively impacted the global blood collection market growth in many regions during the pandemic.

Specific factors driving the market growth include the rising demand for early diagnosis of chronic conditions, increasing incidence of trauma and accidents, and a surge in the number of surgical procedures carried out worldwide.

Blood collection has also witnessed a great demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Cancers such as Leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS) can affect the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic system. It has been observed that apheresis technology has been used to reduce the number of white cells until other medications can control them. According to the Leukemia and Lymphoma Society (LLS) Factsheet 2021, approximately every three minutes, one person in United States is diagnosed with blood cancer. Moreover, as per the same source, 186,400 people in United States will be diagnosed with Leukemia and lymphoma in 2021. In addition, 825,651 people lived with lymphoma in United States, 152,671 people resided with Hodgkin lymphoma, and 672,980 people lived with non-Hodgkin lymphoma.

Moreover, the growing number of accidents also boosts the market growth. According to the World Health Organization, 2020, 1.35 million people die yearly from road accidents, and 20-50 million suffer from non-fatal injuries. The increasing number of accidents drives the demand for blood products, boosting the market growth.

The steady increase in the number of patients suffering from these diseases and ailments and the growing number of accidents may boost the blood collection market during the forecast period. However, blood contamination, other complications, and injuries caused during the blood collection are the major restraining factor for the market studied.

Key Market Trends

Needles and Syringes are Expected to Hold a Significant Market Share

The immediate detection of COVID-19 cases requires the wide availability of diagnostics to control the virus's rapid spread. A public health emergency was determined, justifying the authorization of emergency use of in vitro diagnostics (IVDs) to diagnose COVID-19, which ultimately drives blood testing worldwide. Hence, the needles and syringes segment is expected to see healthy growth over the forecast period. Using hypodermic needles and syringes is the most common means of blood sampling. Therefore, blood collection needles and syringes are expected to dominate the market owing to their extensive use all across the globe.

Apart from the pandemic, many other infectious diseases are prevalent, increasing the demand for blood specimen collection for diagnosis, thereby boosting the demand for needles and syringes for blood collection. For instance, in the study titled "The Order of Draw during Blood Collection: A Systematic Literature Review," published in the MDPI Journal in February 2021, a syringe with a needle is a common open blood collection system. Syringes are an essential part of any phlebotomist's blood-collection device toolkit. Thus, the demand for syringes and needles in fore blood collection boosted the segment growth over the forecast period.

Various advancements in the field of medical devices are also fueling market growth. For example, According to the study titled "Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles," published in the Hindwi Journal in September 2020, siliconized needles are currently being used in multiple instances to minimize trauma and minimize the risk of vein cross perforation with a short bevel. Because a vast number of injuries occur within seconds after an invasive device is removed from the vein, the majority of the marketed needles provide immediate protection at the puncture site. Hence, this segment is expected to retain its dominance in the global market over the forecast period.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America holds the largest share of the market studied, which is attributed to the increasing demand for blood collection products. An increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market studied. With the COVID-19 impact being the highest in United States, the region foresees good growth in the market during the forecast period.

According to the American National Red Cross, 2021 updated estimates, approximately 36,000 units of red blood cells are needed every day, and nearly 21 million blood components are transfused each year in United States. Additionally, according to the Globocan 2020 report, Canada had 8,506 cases of Non-Hodgkin lymphoma and 313 deaths caused due to it in 2020. The increase in cases of Non-Hodgkin lymphoma is expected to boost the demand for the blood collection market.

However, various strategies acquired by the key market players in the country anticipated market growth. For instance, in December 2021, Ethos Laboratories, a College of American Pathologists-accredited and certified leader in diagnostic testing services, launched Tru-Immune, a finger prick, self-collection kit for its COVID-19 neutralizing antibody test.

Additionally, in December 2021, Tasso, a maker of simplified blood collection devices. After raising only USD 17 million to begin operations in mid-2020, the company has raised USD 100 million to expand its production and commercial reach for advanced at-home blood collection devices. The growing number of chronic diseases and lifestyle-related disorders requires blood collection for their diagnosis, which boosts the region's market growth.

Competitive Landscape

The blood collection market is highly competitive and consists of several major players. Companies like Becton, Dickinson and Company, Cardinal Health, F.L. Medical SRL, Greiner Bio-One International GmbH, Haemonetics Corporation, Henry Schein Inc., McKesson Corporation, Medline Industries Inc., PreQ Systems, and Qiagen, among others, hold substantial shares in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Early Diagnosis of Chronic Conditions
    • 4.2.2 Increasing Incidence of Trauma and Accidents
    • 4.2.3 Surge in the Number of Surgical Procedures Carried Out Worldwide
  • 4.3 Market Restraints
    • 4.3.1 Blood Contaminations and Other Complications
    • 4.3.2 Injury Caused During Blood Collection
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value)

  • 5.1 By Product
    • 5.1.1 Needles and Syringes
    • 5.1.2 Tubes (Plasma-separating Tubes, Serum-separating Tubes, etc.)
    • 5.1.3 Lancets
    • 5.1.4 Blood Bags
    • 5.1.5 Other Products
  • 5.2 By Application
    • 5.2.1 Diagnostics
    • 5.2.2 Treatment
  • 5.3 By End User
    • 5.3.1 Hospitals and Diagnostic Centers
    • 5.3.2 Blood Banks
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Cardinal Health
    • 6.1.3 Terumo Corporation
    • 6.1.4 FRESENIUS KABI
    • 6.1.5 Haemonetics Corporation
    • 6.1.6 Henry Schein Inc.
    • 6.1.7 McKesson Corporation
    • 6.1.8 Medline Industries Inc.
    • 6.1.9 PreQ Systems
    • 6.1.10 Qiagen
    • 6.1.11 Grifols
    • 6.1.12 Smiths Medical
    • 6.1.13 Quest Diagnostics
    • 6.1.14 Nipro Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS